These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23494)

  • 1. [Betadrenol in the hyperkinetic heart syndrome and functional heart disorders].
    Vorberg G
    MMW Munch Med Wochenschr; 1978 Jan; 120(2-3):77-8. PubMed ID: 23494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic problems in hyperkinetic heart syndrome].
    Rameis H; Magometschnigg D
    Acta Med Austriaca; 1984; 11(1):17-22. PubMed ID: 6143464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A; Pyöräiä K
    Duodecim; 1976; 92(11):597-603. PubMed ID: 7445
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intraindividual comparison of 2 bisoprolol dosages in patients with essential hypertension].
    Cardona R; Disselhoff G; Lizarraga P; Orozco M; Perez-Acuna F; Monsalve P; Vera O; Lopez B; Schmidt-Dommerque F; Tremarias A
    Med Klin (Munich); 1986 Apr; 81(9):307-10. PubMed ID: 2878358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects in humans of a new beta adrenergic receptor blocking agent on tachycardia induced with isoprenaline].
    Fuccella LM; Bianchi-Porro G; Foresti A; Mandelli V
    Minerva Cardioangiol; 1973 Dec; 21(12):854-9. PubMed ID: 4149917
    [No Abstract]   [Full Text] [Related]  

  • 9. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of Cordanum in labile hypertension].
    Gerasimiuk PP; Zaporozhets TF; Slobodianik GP
    Vrach Delo; 1982 Nov; (11):29-30. PubMed ID: 6130655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 12. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique.
    Reves JG; Croughwell ND; Hawkins E; Smith LR; Jacobs JR; Rankin S; Lowe J; VanTrigt P
    J Thorac Cardiovasc Surg; 1990 Aug; 100(2):221-7. PubMed ID: 1974664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of celiprolol and placebo in the treatment of hypertension.
    Capone P; Mayol R
    Br J Clin Pract Suppl; 1985 Jun; 40():65-9. PubMed ID: 2864067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study with Tobanum and Visken in hypertensive patients.
    Torma Z; Grubic V; Unyi G
    Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
    [No Abstract]   [Full Text] [Related]  

  • 17. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 18. Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.
    Frick MH; Hartikainen M; Pörsti P
    Ann Clin Res; 1978 Apr; 10(2):105-6. PubMed ID: 28071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J
    Br J Clin Pract; 1985 May; 39(5):188-91. PubMed ID: 2866790
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute effects of beta receptor blockaders in hyperthyroidism].
    Váradi A; Földes J; Gyertyánffy G; Borvendég J; Brüll J
    Orv Hetil; 1981 May; 122(18):1069-72. PubMed ID: 6115351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.